Form 6-K NOVO NORDISK A S For: Nov 13

Go back to Form 6-K NOVO NORDISK A S For: Nov 13

Mikael Dolsten withdraws board candidacy at Novo Nordisk

November 14, 2025 6:19 AM EST

Mikael Dolsten has withdrawn his candidacy for Novo Nordisk's (NYSE: NVO) Board of Directors due to personal circumstances, the Danish pharmaceutical company announced.

Dolsten, who previously served as Head of Research and Development at Pfizer, informed Novo Nordisk that he would not seek election... More